Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated April 13th, 2022

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
Rytelo Gains FDA Approval for Lower-Risk Myelodysplastic Syndrome: Reducing Need For Blood Transfusions & Improving Quality of Life
NOW
PLAYING
Practice-Changing Research Shows Imfinzi, a Type of Immunotherapy, Significantly Increases Survival for Certain Small Cell Lung Cancers
NOW
PLAYING
Promising Targeted Therapy, Padcev, Falls Short of Meeting Goals for Advanced Breast Cancer - But May Still Have Future Treating Disease
NOW
PLAYING
Katie Couric, 67, Urges Eye Cancer Screenings After Friend & Lead Singer of '80s Tribute Band Diagnosed With Uveal Melanoma
NOW
PLAYING
More Progress With Less Intensive Treatment, Crucial New Research For People Battling Cancers Like Ovarian, Esophageal, & Hodgkin Lymphoma
NOW
PLAYING
Practice-Changing Research Indicates Tagrisso Significantly Slows Progression for EGFR-Mutated Stage 3 Lung Cancer

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... colon cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider